Dublin, June 14, 2018 (GLOBE NEWSWIRE) -- The "Global Nitric Oxide Therapy Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering. The global nitric oxide therapy systems market is expected to expand at a CAGR of 5.19% from 2017 to 2025. Durability and lightweight are the meritorious features that increase the demand for portable nitric oxide therapy systems. Relatively low cost, versatility and easy fabrication of the auxiliary holding devices with the main ventilation unit makes fixed nitric oxide therapy systems a lucrative option in the ambulatory care and hospitals. Hospitals and clinics widely utilize the nitric oxide inhalation therapy in the neonate and intensive care unit to address ailments related to pulmonary disorders and increasing demand for pediatric cardiopulmonary bypass surgery procedures for treating cardiopulmonary ailments. Homecare settings finds huge application of nitric oxide therapy systems for the rehabilitation of geriatric patients suffering with acute respiratory distress syndrome. North America is the market leader in nitric oxide therapy systems due to the rising prevalence of acute respiratory distress syndrome in the adult population and the presence of key players actively engaged in the manufacturing of nitric oxide therapy systems. Asia Pacific will dominate the market in the near future on account of the rising prevalence of neonate pulmonary hypertension. Competitive market formed due to the emergence of local providers of nitric oxide therapy systems contribute to the growth of Asia Pacific market. Key Market Movements:
- Rising prevalence of neonatal pulmonary hypertension and acute respiratory distress syndrome
- Recent technical advancements in the manufacturing of nitric oxide therapy systems will contribute to its market growth
- Supportive regulatory environment for nitric oxide therapy systems
Key Topics Covered: Chapter 1. Preface 1.1. Report Scope and Description 1.2. Research Methodology Chapter 2. Executive Summary 2.1. Global Nitric Oxide Therapy Systems Market Portraiture 2.1.1. Global Nitric Oxide Therapy Systems Market, by Type, 2016 2.1.2. Global Nitric Oxide Therapy Systems Market, by End Users, 2016 2.1.3. Global Nitric Oxide Therapy Systems Market, by Geography, 2016 Chapter 3. Nitric Oxide Therapy Systems Market: Dynamics and Future Outlook 3.1. Market Overview 3.2. Drivers 3.3. Challenges 3.4. Opportunities 3.5. Porter's Five Forces Analysis 3.6. Attractive Investment Proposition, by Geography 3.7. Top 3 Countries: Global Nitric Oxide Therapy Systems Market, 2015-2025 (US$ Mn) 3.8. Competitive Landscape: Global Nitric Oxide Therapy Systems Market, by Key Players, 2015-2025 (US$ Mn) Chapter 4. Global Nitric Oxide Therapy Systems Market, by Type, 2015 - 2025 (US$ Mn) 4.1. Overview 4.2. Portable Nitric Oxide Therapy Systems 4.3. Fixed Nitric Oxide Therapy Systems Chapter 5. Global Nitric Oxide Therapy Systems Market, by End Users, 2015 - 2025 (US$ Mn) 5.1. Overview 5.2. Hospitals 5.3. Homecare Settings 5.4. Clinics Chapter 6. Global Nitric Oxide Therapy Systems Market, by Geography, 2015 - 2025 (US$ Mn) Chapter 7. Company Profiles
- Bellerophon Therapeutics
- BOC Healthcare
- Dan Hammer Health Ltd.
- EKU Elektronik GmbH
- GeNO, LLC
- International Biomedical
- SLE
- Mallinckrodt Pharmaceuticals
- Praxair, Inc.
- Vapotherm
For more information about this report visit https://www.researchandmarkets.com/research/8...itric?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
